Liver function trends in children with suspected drug‐induced hepatocellular injury: A survey using an electronic medical records database
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.15847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 18.02.2025. Verfasst von Masayoshi Nakakuni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Research and Development, National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Drug‐induced liver injury (DILI) is a common adverse drug event with limited pediatric data in the literature. This study aimed to use pediatric electronic medical records to assess hepatocellular DILI in pediatric patients who were prescribed liver‐injury‐inducing drugs.
Methods
The Pediatric Medical Information Collection System (P‐MICS) is a centralized database integrating electronic medical records from over 40 medical pediatric centers. Pediatric patients in the P‐MICS with serum alanine aminotransferase (ALT) levels five or more times the upper limit of normal and who were below 15 years of age were selected. Those with liver diseases unrelated to drug‐induced causes were excluded. We identified drugs prescribed 2 to 90 days before the first elevated ALT reading. High‐risk liver‐injury‐causing drugs were determined based on the LiverTox score. We analyzed post‐event ALT and total bilirubin levels (TB) and DILI management.
Results
Of the 817 patients with suspected DILI, 251 were prescribed four drugs identified as high‐risk drugs for hepatocellular DILI: methotrexate ( n = 129), aspirin ( n = 82), vancomycin ( n = 58), and cyclophosphamide ( n = 51). The median ALT level at the first event was 245 U/L. Approximately 35% of methotrexate users and cyclophosphamide users experienced recurrent ALT elevation. Some methotrexate users also showed TB elevation. Discontinuation of high‐risk drugs resulted in fewer relapses and TB elevations than pharmacotherapy.
Conclusions
The P‐MICS effectively identifies pediatric patients with potential liver injury and tracks liver function in those prescribed liver‐injury‐causing drugs. This study underscores liver injury risks in pediatric anticancer drug users, highlighting the utility of the P‐MICS in monitoring off‐label drug safety in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Research and Development, National Center for Child Health and Development, Tokyo, Japan.
- Social Pharmacy and Regulatory Science, Showa Pharmaceutical University, Tokyo, Japan.
- Department Pediatric Hepatology and Gastroenterology, Saiseikai Yokohamashi Tobu Hospital, Kanagawa, Japan.
- Nature Insight Co., Ltd., Tokyo, Japan.
- Pharmacoepidemiology, Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan.
ORCID-Profile: Masayoshi Nakakuni
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Nakakuni, M., Nakano, K., Inui, A., Kobayashi, S., Deguchi, N., Mitsui, S., Kuriyama, T., & Miyazaki, S. (2025). Liver function trends in children with suspected drug‐induced hepatocellular injury: A survey using an electronic medical records database. Pediatrics International, 67(1). https://doi.org/10.1111/ped.15847
Vancouver
Nakakuni M, Nakano K, Inui A, Kobayashi S, Deguchi N, Mitsui S, et al. Liver function trends in children with suspected drug‐induced hepatocellular injury: A survey using an electronic medical records database. Pediatrics International. 2025;67(1). doi:10.1111/ped.15847
BibTeX
@article{Nakakuni2025,
author = {Nakakuni, Masayoshi and Nakano, Kosuke and Inui, Ayano and Kobayashi, Shinji and Deguchi, Naoko and Mitsui, Seiji and Kuriyama, Takeshi and Miyazaki, Seiko},
title = {Liver function trends in children with suspected drug‐induced hepatocellular injury: A survey using an electronic medical records database},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.15847}
}
EUVIMED